论文部分内容阅读
胞浆内精子注射(ICSI)为治疗男性因素不育的标准方法。ICSI治疗的范围已扩大到无顶体精子,原因不明的不孕症,临界的精液,免疫不孕和以前常规体外受精(IVF)失败的病人。对梗阻或非梗阻性无精子病人,从附睾或睾丸手术取精子进行ICSI也有成功的报道。 350例病人进行366周期ICSI。按照ICSI指征,病人依精液质量和来源分为5组,1组男
Intracytoplasmic sperm injection (ICSI) is the standard method of treating male infertility. The scope of ICSI therapy has been extended to patients with no acrosome sperm, unexplained infertility, borderline semen, immunological infertility, and previous conventional IVF failure. ICSI has also been reported successfully in patients with obstructive or non-obstructive azoospermia who take sperm from epididymal or testicular surgery. 350 patients performed 366 cycles of ICSI. According to ICSI indications, the patients were divided into 5 groups according to semen quality and origin, 1 group of men